Start here if you're new
what it is
VirnetX sells secure communication software and patented network tools for government and enterprise users.
how it gets paid
Last year Virnetx made $5K in revenue. patent licensing was the main engine at $2.5K, or 50% of sales.
what just happened
Revenue hit $106K, but EPS landed at -$3.17.
At a glance
C++ balance sheet — some cracks in the foundation
5/100 earnings predictability — expect surprises
72.3% return on capital — a money-printing machine
-$5.05 fy2024 eps est
$0M fy2024 rev est
xvary composite: 43/100 — below average
What they do
VirnetX sells secure communication software and patented network tools for government and enterprise users.
The moat is patents plus a GSA contract. That means buyers can buy under preset terms instead of starting from scratch. You are looking at 23 employees selling a security stack built for government and enterprise traffic.
How they make money
$5K
annual revenue
patent licensing
$2.5K
government software sales
$1.2K
maintenance and support
$0.7K
contract services
$0.4K
other
$0.2K
The products that matter
intellectual property licensing
Patent Portfolio
$106K · effectively 100% of revenue
it generated the company's full $106K in trailing revenue. if this line does not improve, the commercial case stays theoretical.
the whole business
secure communication software
Gabriel Collaboration Technology
$0 disclosed product revenue
it sits inside the zero-trust pitch, but there is still $0 of disclosed product revenue attached to it. you are being asked to underwrite optionality, not traction.
optional, not proven
Key numbers
-$5.05
fy2024 eps est
$0M
fy2024 rev est
n/a
trailing p/e
n/a
dividend yield
Financial health
C++
strength
- balance sheet grade C++ — below average — limited financial resources
- risk rank 4 — safer than 20% of stocks
- price stability 5 / 100
C++ — below average. watch for debt servicing and cash burn.
Total return vs. market
Return history isn't available for VHC right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Revenue hit $106K, but EPS landed at -$3.17.
Revenue rose 83% from the prior year, but the base is still tiny. A $106K quarter does not cover a $3.17 loss per share.
$106K
revenue
$3.17
eps
+83%
revenue growth
revenue base
The $106K quarter matters because it is the size of the whole engine. One contract or one legal check can swing this business.
source: company earnings report, 2025
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is patent monetization never becoming repeatable revenue. if the legal assets do not turn into cash at a bigger scale, there is very little operating business here to fall back on.
med
all reported revenue sits in one tiny line
Trailing revenue is $106K and effectively all of it comes from patent licensing. There is no second engine if that line stays flat.
If licensing or settlement economics disappoint, you are exposing essentially 100% of the current revenue base.
med
software still has $0 of disclosed product revenue
Gabriel Collaboration Technology may be the future pitch, but the disclosed commercial result is still $0. That means investors are valuing a possibility, not adoption.
If product traction never shows up, the stock stays tied to patent outcomes instead of building an operating multiple.
med
losses are hitting a weak balance sheet
A -25.12% return on assets and a C++ balance sheet grade tell you the burn is not abstract. It is landing on a financial profile that already looks below average.
If the current pattern continues without a licensing win or product revenue, the path toward financing pressure gets easier to see.
A $70M market cap against $106K of trailing revenue leaves almost no room for the story to stay theoretical. If the patent case stays thin and software revenue stays at $0, the equity case gets thinner with it.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
whether revenue stops rounding to zero
The whole trailing business is $106K, and the latest quarter was $50K. Until that changes, every other narrative is secondary.
calendar
march 17, 2026 shareholder meeting
This is the next scheduled forum for management to explain patent strategy, cash use, and what the software effort is actually doing commercially.
risk
cash burn against a C++ balance sheet
Losses are ongoing and the financial profile is already below average. If monetization stays weak, balance-sheet pressure becomes part of the thesis.
trend
whether software becomes more than a slide
Gabriel Collaboration Technology has a narrative. It does not yet have disclosed product revenue. That gap is the entire commercialization question.
Analyst rankings
earnings predictability
5 / 100
in human-speak: there is very little stable operating history here, so clean forecasts are harder to trust than usual.
xvary read-through
below average
This score reflects tiny revenue, ongoing losses, and a business model that still depends more on legal outcomes than repeatable selling.
source: institutional data
Institutional activity
institutional ownership data for VHC is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$20
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive